BioCentury
ARTICLE | Company News

Cancer Genetics sales and marketing update

April 14, 2014 7:00 AM UTC

Cancer Genetics launched its CALR mutation analysis test to help diagnose patients with essential thrombocythemia and primary myelofibrosis. The company offers the PCR-based test, which detects mutat...